As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
The global COVID-19 diagnostics market is being aided by the growing cases of COVID-19 infections in the United States, which has performed around 390 million tests for COVID-19 as of March 2021.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The large and growing number of coronavirus patients in nations, such as India, with a huge population base, is leading to a rapid increase in the demand for COVID-19 testing kits and diagnostic tools in the Asia Pacific region. The diagnostic facilities in the Asia Pacific have been witnessing a continuous expansion, with the government initiating mass testing programmes to tackle the pandemic. The implementation of various government initiatives, like the Indian government’s plan to expand the number of rapid action antigen kits for more rigorous detection of COVID-19, have been favourable for the growth of the COVID-19 diagnostics industry.
North America is also substantially adding to the demand for COVID-19 testing kits and diagnostic tests, owing to the exorbitant number of active coronavirus patients in the United States. The United States and Canada have granted emergency use authorisation to COVID-19 diagnostic kits in order to expand the testing capacity. This has provided a further thrust to the growth of the COVID-19 diagnostics industry.
COVID-19 is a single-stranded RNA coronavirus that infects the respiratory system of the human body and is generally spread through the close contact with an infected patient by coughing or sneezing. COVID-19 diagnostics refer to the processes of analysing test samples to detect either the current or recent presence of SARS-CoV-2. The diagnostic kits detect the presence of the virus or antibodies produced in response to the infection.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By test type, the market is segmented into:
Based on product, the industry is divided into the following:
On the basis of sample type, the market is segmented into:
By business model, the market is divided into:
The end uses for the industry are categorised into the following segments:
The regional markets for the COVID-19 diagnostics industry can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The introduction of new and improved technology has helped in the active detection of coronavirus patients and checked the uncontrolled growth of infections across the world. The key players in the industry have invested heavily to produce better COVID-19 testing and diagnostic kits, with improved accuracy and lower time of testing, further propelling the growth of the market. The surge of the second wave of the coronavirus pandemic around the world has alerted governments of different nations and increased the testing to better control the virus, thus, catalysing the growth of the market. The increasing initiation of drive-in and walk-through testing centres, which have made the process of testing convenient, have also accelerated the market growth for COVID-19 diagnostics.
The report gives a detailed analysis of the following key players in the global COVID-19 diagnostics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.
|Scope of the Report||Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Test Type, Product, Sample Type, Business Model, End Use, Region|
|Breakup by Test Type||PCR Test, Antigen Test, Antibody Test, Others|
|Breakup by Product||RT-PCR Assay Kits, Immunoassay Test Strips, Others|
|Breakup by Sample Type||Nasopharyngeal Swab, Oropharyngeal (OP) Swab, Nasal Swab, Blood Test, Others|
|Breakup by Business Model||Point-of-Care (PoC) Testing, Non-Point-of-Care (PoC) Testing|
|Breakup by End Use||Hospitals, Diagnostic Centres and Clinics, Laboratories, Others|
|Breakup by Region||North America, Latin America, Europe, Middle East and Africa, Asia Pacific|
|Market Dynamics||SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand|
|Competitive Landscape||Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications|
|Companies Covered||F. Hoffmann-La Roche Ltd, Abbott Laboratories, Thermo Fisher Scientific Inc, Guangzhou Wondfo Biotech Co., Ltd., Altona Diagnostics GmbH, Mylab Discovery Solutions Pvt. Ltd., Others|
|Report Price and Purchase Option||Explore our purchase options that are best suited to your resources and industry needs.|
|Delivery Format||Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.|
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
7 Industry Opportunities and Challenges
8 Global COVID-19 Overview
8.1 Global Number of COVID-19 Cases
8.2 Global COVID-19 Cases by Region
8.2.1 North America
8.2.3 Asia Pacific
8.2.4 Latin America
8.2.5 Middle East and Africa
9 Global COVID-19 Diagnostics Market Analysis
9.1 Key Industry Highlights
9.2 Global COVID-19 Diagnostics Market (2020-2026)
9.3 Global COVID-19 Diagnostics Market by Test Type (2020-2026)
9.3.1 PCR Test
9.3.2 Antigen Test
9.3.3 Antibody Test
9.4 Global COVID-19 Diagnostics Market by Product (2020-2026)
9.4.1 RT-PCR Assay Kits
9.4.2 Immunoassay Test Strips
9.5 Global COVID-19 Diagnostics Market by Sample Type (2020-2026)
9.5.1 Nasopharyngeal Swab
9.5.2 Oropharyngeal (OP) Swab
9.5.3 Nasal Swab
9.5.4 Blood Test
9.6 Global COVID-19 Diagnostics Market by Business Model (2020-2026)
9.6.1 Point-of-Care (PoC) Testing
9.6.2 Non-Point-of-Care (PoC) Testing
9.7 Global COVID-19 Diagnostics Market by End Use (2020-2026)
9.7.2 Diagnostic Centres and Clinics
9.8 Global COVID-19 Diagnostics Market by Region (2020-2026)
9.8.1 North America
18.104.22.168 United States of America
22.214.171.124 United Kingdom
9.8.3 Asia Pacific
9.8.4 Latin America
9.8.5 Middle East and Africa
126.96.36.199 Saudi Arabia
188.8.131.52 United Arab Emirates
184.108.40.206 South Africa
10 Market Dynamics
10.1 SWOT Analysis
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 F. Hoffmann-La Roche Ltd
220.127.116.11 Company Overview
18.104.22.168 Product Portfolio
22.214.171.124 Demographic Reach and Achievements
11.2.2 Abbott Laboratories
126.96.36.199 Company Overview
188.8.131.52 Product Portfolio
184.108.40.206 Demographic Reach and Achievements
11.2.3 Thermo Fisher Scientific Inc
220.127.116.11 Company Overview
18.104.22.168 Product Portfolio
22.214.171.124 Demographic Reach and Achievements
11.2.4 Guangzhou Wondfo Biotech Co., Ltd.
126.96.36.199 Company Overview
188.8.131.52 Product Portfolio
184.108.40.206 Demographic Reach and Achievements
11.2.5 Altona Diagnostics GmbH
220.127.116.11 Company Overview
18.104.22.168 Product Portfolio
22.214.171.124 Demographic Reach and Achievements
11.2.6 Mylab Discovery Solutions Pvt. Ltd.
126.96.36.199 Company Overview
188.8.131.52 Product Portfolio
184.108.40.206 Demographic Reach and Achievements
12 Industry Events and Developments
List of Figures and Tables
1. Global COVID-19 Cases by Region
2. Global COVID-19 Diagnostics Market: Key Industry Highlights, 2020 and 2026
3. Global COVID-19 Diagnostics Market: Breakup by Test Type (USD Billion)
4. Global COVID-19 Diagnostics Market: Breakup by Product (USD Billion)
5. Global COVID-19 Diagnostics Market: Breakup by Sample Type (USD Billion)
6. Global COVID-19 Diagnostics Market: Breakup by Business Model (USD Billion)
7. Global COVID-19 Diagnostics Market: Breakup by End Use (USD Billion)
8. Global COVID-19 Diagnostics Market: Breakup by Region (USD Billion)
9. North America COVID-19 Diagnostics Market: Breakup by Country (USD Billion)
10. Europe COVID-19 Diagnostics Market: Breakup by Country (USD Billion)
11. Asia Pacific COVID-19 Diagnostics Market: Breakup by Country (USD Billion)
12. Latin America COVID-19 Diagnostics Market: Breakup by Country (USD Billion)
13. Middle East and Africa COVID-19 Diagnostics Market: Breakup by Country (USD Billion)
14. Global COVID-19 Diagnostics Market Structure
The global COVID-19 diagnostics market is being aided by the growing cases of COVID-19 infections in the United States of America, which have performed nearly 390 million tests for COVID-19 as of March 2021.
The major drivers of the industry, such as the growing number of COVID-19 cases, favourable government policies, and growing investments into streamlining the diagnostic process, are aiding the market growth.
The key market trends guiding the growth of the industry include the growing technological advancements and increasing R&D activities.
The major regions in the industry are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The significant test types available in the industry are PCR test, antigen test, and antibody test, among others.
The leading products available in the industry are RT-PCR assay kits and immunoassay test strips, among others.
The major sample types available in the market are nasopharyngeal swab, oropharyngeal (OP) swab, nasal swab, and blood test, among others.
The significant business models in the industry are point-of-care (PoC) testing and non-point-of-care (PoC) testing.
The leading end use sectors in the industry are hospitals, and diagnostic centres and clinics, laboratories, among others.
The major players in the industry are F. Hoffmann-La Roche Ltd, Abbott Laboratories, Thermo Fisher Scientific Inc, Guangzhou Wondfo Biotech Co., Ltd., Altona Diagnostics GmbH, and Mylab Discovery Solutions Pvt. Ltd., among others.
The global COVID-19 diagnostics market is being aided by the growing cases of COVID-19 infections in the United States of America, which had performed about 390 million tests for COVID-19 as of March 2021. The market is further being driven by the growing investments into the industry by the key players and the governments globally.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its test types, the COVID-19 diagnostics industry can be segmented into PCR test, antigen test, and antibody test, among others. On the basis of products, the industry is divided into RT-PCR assay kits and immunoassay test strips, among others. By sample types, the industry is categorised into nasopharyngeal swab, oropharyngeal (OP) swab, nasal swab, and blood test, among others. On the basis of business models, the industry is segmented into point-of-care (PoC) testing and non-point-of-care (PoC) testing. Based on end uses, the industry is segregated into hospitals, diagnostic centres and clinics, and laboratories, among others. The major regional markets for COVID-19 diagnostics are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include F. Hoffmann-La Roche Ltd, Abbott Laboratories, Thermo Fisher Scientific Inc, Guangzhou Wondfo Biotech Co., Ltd., Altona Diagnostics GmbH, and Mylab Discovery Solutions Pvt. Ltd., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.